US 12383631
Immune antigen specific IL-18 immunocytokines and uses thereof
granted A61KA61K47/6813A61K47/6849
Quick answer
US patent 12383631 (Immune antigen specific IL-18 immunocytokines and uses thereof) held by Bright Peak Therapeutics AG expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bright Peak Therapeutics AG
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K47/6813, A61K47/6849, A61K47/6851, A61K47/6863